HTG Molecular Diagnostics, Inc. Deferred Tax Assets, Other
HTG Molecular Diagnostics, Inc. had Deferred Tax Assets, Other of $755.03 thousand as of 2022-12-31, per its 10-K filed 2023-03-30.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOther · last filed 2023-03-30
- 2022-12-31: Deferred Tax Assets, Other $755.03K.
- 2021-12-31: Deferred Tax Assets, Other $711.34K.
- 2020-12-31: Deferred Tax Assets, Other $211.57K.
- 2019-12-31: Deferred Tax Assets, Other $150.13K.
| Period end | Deferred Tax Assets, Other |
|---|---|
| 2022-12-31 | $755.03K 10-K · filed 2023-03-30 |
| 2021-12-31 | $711.34K 10-K · filed 2023-03-30 |
| 2020-12-31 | $211.57K 10-K · filed 2022-03-29 |
| 2019-12-31 | $150.13K 10-K · filed 2021-03-25 |
| 2018-12-31 | $106.91K 10-K · filed 2020-03-25 |
| 2017-12-31 | $74.99K 10-K · filed 2019-03-07 |
| 2016-12-31 | $233.44K 10-K · filed 2018-03-23 |
| 2015-12-31 | $115.79K 10-K · filed 2017-03-23 |
| 2014-12-31 | $85.29K 10-K · filed 2016-03-25 |